EVEN-PLUS SYNDROME
|
0.720 |
GeneticVariation
|
disease |
BEFREE |
Combined, our biophysical and structural studies contribute to the understanding of the molecular basis for how disease-associated mortalin mutations affect mortalin functionality and the pathogenesis of EVEN-PLUS syndrome.
|
30933555 |
2019 |
EVEN-PLUS SYNDROME
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in the heat-shock protein A9 (HSPA9) gene cause the EVEN-PLUS syndrome of congenital malformations and skeletal dysplasia.
|
26598328 |
2015 |
EVEN-PLUS SYNDROME
|
0.720 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in the heat-shock protein A9 (HSPA9) gene cause the EVEN-PLUS syndrome of congenital malformations and skeletal dysplasia.
|
26598328 |
2015 |
EVEN-PLUS SYNDROME
|
0.720 |
Biomarker
|
disease |
BEFREE |
Mutations in the heat-shock protein A9 (HSPA9) gene cause the EVEN-PLUS syndrome of congenital malformations and skeletal dysplasia.
|
26598328 |
2015 |
EVEN-PLUS SYNDROME
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in the heat-shock protein A9 (HSPA9) gene cause the EVEN-PLUS syndrome of congenital malformations and skeletal dysplasia.
|
26598328 |
2015 |
EVEN-PLUS SYNDROME
|
0.720 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutations in the heat-shock protein A9 (HSPA9) gene cause the EVEN-PLUS syndrome of congenital malformations and skeletal dysplasia.
|
26598328 |
2015 |
EVEN-PLUS SYNDROME
|
0.720 |
GermlineCausalMutation
|
disease |
ORPHANET |
Epiphyseal, vertebral, and ear (EVE) dysplasia: a new syndrome?
|
10424819 |
1999 |
EVEN-PLUS SYNDROME
|
0.720 |
Biomarker
|
disease |
CTD_human |
|
|
|
EVEN-PLUS SYNDROME
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
EVEN-PLUS SYNDROME
|
0.720 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Sideroblastic anemia
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Congenital sideroblastic anemia due to mutations in the mitochondrial HSP70 homologue HSPA9.
|
26491070 |
2015 |
ANEMIA, SIDEROBLASTIC, 4
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Congenital sideroblastic anemia due to mutations in the mitochondrial HSP70 homologue HSPA9.
|
26491070 |
2015 |
ANEMIA, SIDEROBLASTIC, 4
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Congenital sideroblastic anemia due to mutations in the mitochondrial HSP70 homologue HSPA9.
|
26491070 |
2015 |
Sideroblastic anemia
|
0.600 |
Biomarker
|
disease |
HPO |
|
|
|
Sideroblastic anemia
|
0.600 |
Biomarker
|
disease |
CTD_human |
|
|
|
ANEMIA, SIDEROBLASTIC, 4
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
ANEMIA, SIDEROBLASTIC, 4
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Parkinson Disease
|
0.400 |
Biomarker
|
disease |
BEFREE |
This preliminary study summarized that Mortalin plays a significant role in PD with negative correlation with α-Syn.
|
29307058 |
2018 |
Parkinson Disease
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
However, to date, mortalin expression has not yet been evaluated in astrocytes of post-mortem brain tissue from either normal or PD subjects.
|
26095919 |
2016 |
Parkinson Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The expression of mortalin decreased significantly in dopaminergic cells overexpressing A53T α-syn; furthermore, the down-regulation of mortalin could attenuate the disrupted mitochondrial dynamics by reducing α-syn translocation to mitochondria, suggesting that a compensatory mechanism of mortalin might be implicated in the pathogenesis of PD.
|
25665531 |
2015 |
Parkinson Disease
|
0.400 |
Biomarker
|
disease |
BEFREE |
These factors may mediate the transformation of longevity/pro-proliferative function of mot-2 to the premature aging/anti-proliferative effect of mutants, and hence may have significance in cellular aging, Parkinson disease pathology, and prognosis.
|
25645922 |
2015 |
Parkinson Disease
|
0.400 |
Biomarker
|
disease |
BEFREE |
Mortalin dysfunction associated with Parkinson's disease (PD) increases the vulnerability of cultured cells to proteolytic stress and leads to changes in mitochondrial function and morphology.
|
24386261 |
2013 |
Parkinson Disease
|
0.400 |
Biomarker
|
disease |
BEFREE |
Dysfunctional mitochondria and the mitochondrial chaperone mortalin (HSPA9, GRP75) have been implicated in the pathogenesis of Parkinson disease (PD).
|
23831374 |
2013 |
Parkinson Disease
|
0.400 |
Biomarker
|
disease |
BEFREE |
Mortalin also interacts with a variety of PD-related proteins and plays an indispensible role in helping native protein refolding and importing proteins into the mitochondrial matrix.
|
21640711 |
2011 |
Parkinson Disease
|
0.400 |
Biomarker
|
disease |
BEFREE |
Dissecting the role of the mitochondrial chaperone mortalin in Parkinson's disease: functional impact of disease-related variants on mitochondrial homeostasis.
|
20817635 |
2010 |